Description
Price: $8.78
(as of Nov 11, 2024 14:33:31 UTC – Details)
XL-3 is an excellent option to support the improvement of cold symptoms. It is an over-the-counter product that will help you to reduce the discomfort of the flu or common colds, such as fever, nasal congestion, runny nose, sneezing, watery eyes, aches, and pains, without causing you drowsiness. The influenza virus causes the flu to spread from person to person and can lead to significant complications if left untreated. This pack includes 20 tablets for quick, temporary relief from the annoying symptoms of the common cold. Our cold formula will help you feel better to enjoy your day; it works three times faster than other products. Whether you have a headache, muscle pain, back pain, or other discomforts caused by the common cold or flu, in XL-3, you will find the immediate improvement you were looking for in these symptoms. Use our OTC product according to the instructions. With XL-3, say goodbye to the flu as quick as a wink!
Product Dimensions : 1.7 x 4.5 x 3.05 inches; 1.45 ounces
Date First Available : September 18, 2020
Manufacturer : SELDER
ASIN : B08J94W4N1
Country of Origin : USA
NON-DROWSY. XL-3 will help you temporarily relieve the symptoms of the flu or the common cold without being drowsy all day, so you can be able to carry out your daily activities
FEVER RELIEF. Our product helps reduce fever, and provides temporary relief from headache, sore throat, muscle aches, inflammation, and minor discomfort
DECONGESTANT. It works by reducing blood flow in the upper respiratory tract (nose and throat). Reduces inflammation and mucus production, helping to alleviate the frequent runny nose in flu processes
ANTI-NASAL LEAKAGE AND ALLERGY. XL-3 will enhance flu symptoms and excessive mucus generation, congestion, watery eyes, and sneezing, without being drowsy all day
XL-3 helps treat allergies, burning eyes, runny nose, and other symptoms of the common cold. By using our formula, you will feel a noticeable improvement
Reviews
There are no reviews yet.